Tag: commercial rights
July 15, 2018
5 Top Weekly NASDAQ Biotech Stocks: Arbutus on Top
Adamis Pharmaceutical, Juniper Pharmaceuticals, Anavex Life Sciences, Arbutus BioPharma and Soleno Therapeutics were last week's top gainers on the NASDAQ...
July 2, 2018
4 Top Pharma Stocks on the TSX of Q2 2018
As investors look ahead to the remainder of 2018, we've put together a list of the top-gaining pharmaceutical stocks on... May 8, 2018
Aeglea BioTherapeutics Provides Corporate Update and Reports First Quarter 2018 Financial Results
Aeglea BioTherapeutics (NASDAQ:AGLE), a clinical-stage biotechnology company that designs and develops innovative human enzyme therapeutics for patients with rare genetic... April 29, 2018
5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent
Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ. April 16, 2018
BeiGene Initiates Global Phase 2 Trial of Anti-PD-1 Antibody Tislelizumab in Patients with Relapsed or Refractory Mature T-and NK-Cell Lymphomas
BeiGene (NASDAQ:BGNE), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative molecularly targeted and immuno-oncology drugs for the treatment of...
April 1, 2018
5 Top NASDAQ Biotech Stocks: Cardiome on Top
Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices. March 18, 2018